Abstract
Objective: Trans–catheter aortic valve replacement (TAVR) has been widely adopted as a reasonable alternative to treat severe aortic stenosis in high-risk or inoperable patients. The efficacy and safety analysis of TAVR in most countries have been based on outcomes that followed their practice guidelines and monitoring protocols. The purpose of this paper is to share our experience regarding the process for establishing guidelines and monitoring protocols for treating patients in Korea in the hope that it may be helpful to others undergoing a similar process in their own countries.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
